Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
- Maeve A. Hennessy
- , Jeffrey P. Leal
- , Chiung Yu Huang
- , Lilja B. Solnes
- , Rita Denbow
- , Vandana G. Abramson
- , Lisa A. Carey
- , Minetta C. Liu
- , Mothaffar Rimawi
- , Jennifer Specht
- , Anna Maria Storniolo
- , Vicente Valero
- , Christos Vaklavas
- , Eric P. Winer
- , Ian E. Krop
- , Antonio C. Wolff
- , Ashley Cimino-Mathews
- , Richard L. Wahl
- , Vered Stearns
- , Roisin M. Connolly
- Johns Hopkins University
- University of California at San Francisco
- Vanderbilt University
- University of North Carolina at Chapel Hill
- Mayo Clinic Rochester, MN
- Baylor College of Medicine
- University of Washington
- Indiana University-Purdue University Indianapolis
- University of Texas MD Anderson Cancer Center
- University of Alabama at Birmingham
- Yale University
- Washington University St. Louis
Research output: Contribution to journal › Article › peer-review